Actos
Actos May Raise Bladder Cancer Risk
Actos Bladder Cancer Risk. In an updated review, the U.S. Food and Drug Administration (FDA) said it still believes that use of the type 2 diabetes drug Actos (pioglitazone) may be associated with an increased risk of bladder cancer. The label on drugs containing pioglitazone, including Actos, Actoplus Met, Actoplus Met XR, … [Read more...] about Actos May Raise Bladder Cancer Risk
Actos Cardiac Injury Lawsuit
Actos Cardiac Injury, Stroke & heart failure - Injuries, Lawsuit. Using Actos to treat type 2 diabetes can cause serious Actos side effects that injure the heart, including: Congestive Heart Failure Heart Attack Stroke Cardiovascular Death Victims of Actos heart attacks, congestive heart failure and other Actos side … [Read more...] about Actos Cardiac Injury Lawsuit
Diabetes Drug, Actos, and the Risks of Bladder Cancer and Other Serious Side Effects
Diabetes Drug Risk Of Cancer And Other Side Effects. The U.S. Food and Drug Administration (FDA) approved Actos, which is manufactured by Takeda Chemical Industries, on July 15, 1999. Actos includes the active ingredient pioglitazone hydrochloride and is used for treatment of Type 2 and Type 1 diabetes; Type 1 diabetes mellitus; … [Read more...] about Diabetes Drug, Actos, and the Risks of Bladder Cancer and Other Serious Side Effects
FDA Says Actos May Raise Risk of Bladder Cancer
FDA Concludes Actos May be Linked to Bladder Cancer. The U.S. Food and Drug Administration (FDA) has concluded that pioglitazone, sold under the brand names Actos, Actoplus Met, Actoplus Met XR, Duetact and Oseni, may be associated with an increased risk of bladder cancer. The agency issued a Dec. 12, 2016 Safety … [Read more...] about FDA Says Actos May Raise Risk of Bladder Cancer
Actos Lawsuits Timeline
Actos Can Cause Bladder Cancer. Actos, known generically as pioglitazone, is a medication used to treat patients with Type 2 diabetes. Takeda Pharmaceutical and Eli Lilly gained approval to sell the drug in the United States in 1999, although the drug is now solely manufactured by Takeda in the US. Actos is part of the … [Read more...] about Actos Lawsuits Timeline
Actos Side Effect Lawsuits
If you or a loved one suffered from any of these Actos Side Effect, you may be entitled to receive compensation for your injuries. Hundreds of Actos side effect victims have already filed Actos lawsuits against Takeda Pharmaceuticals for allegedly failing to warn of serious Actos injuries. The Actos lawyers at Parker … [Read more...] about Actos Side Effect Lawsuits
Actos Macular Edema Lawsuit
Actos Macular Edema Injury Lawsuits. If you took Actos and developed diabetic macular edema, the type 2 diabetes drug could be to blame. Diabetic macular edema is an Actos side effect that can develop following cataract surgery, though the condition can develop in the absence of such surgery. In the Summer of 2012, a study … [Read more...] about Actos Macular Edema Lawsuit
Actos Macular Edema Lawyers
Actos Macular Edema Lawsuits. Type 2 diabetics who use Actos (rosiglitazone) may be in danger of developing diabetic macular edema, a serious eye disorder that can result in vision loss. In June 2012, a study published in the Archives of Internal Medicine found that patients taking thiazolidinediones, a class of type 2 diabetes … [Read more...] about Actos Macular Edema Lawyers
Actos Heart Attack Lawsuit | Actos Lawsuits
Actos Heart Attack Injury Lawsuits. If you or someone you love have used the diabetes drug Actos, and suffered an Actos heart attack, this popular type 2 diabetes drug could be to blame. Recent research has linked Actos and other type 2 diabetes drugs known as thiazolidinediones with the side effects of heart attacks, strokes and … [Read more...] about Actos Heart Attack Lawsuit | Actos Lawsuits
Actos Side Effects Lawsuits
Actos Colon Cancer Injury Lawsuits. Many respected studies have linked the Type 2 diabetes medication, Actos (pioglitazone HCI), to increased risks of developing bladder cancer. The Actos lawyers at Parker Waichman LLP are investigating a growing range of Actos side effects in addition to increased bladder cancer risks, … [Read more...] about Actos Side Effects Lawsuits
Actos Bladder Cancer Lawsuit FAQs
What is Actos Bladder Cancer? Actos (pioglitazone) is an anti-diabetic drug (of the thiazolidinedione-type, also called "glitazones") that should be taken in conjunction with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes (also known as non-insulin-dependent diabetes). It works by … [Read more...] about Actos Bladder Cancer Lawsuit FAQs
Takeda Agrees to $2.4B Settlement in Actos Cases
Takeda Settlement In Actos Bladder Cancer Cases. Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits from patients and families who said Takeda’s diabetes drug Actos caused bladder cancer. Takeda, based in Japan, said the settlement would resolve most of the lawsuits related to Actos … [Read more...] about Takeda Agrees to $2.4B Settlement in Actos Cases
Takeda Offers $2.2B to Settle Actos Claims
Actos Settlement Over Defective Drugs And Medical Devices Lawsuits. A potential upcoming Actos settlement would be one of the largest settlements in US history of patients’ lawsuits over defective drugs and medical devices. Bloomberg reports that according to three sources familiar with the situation, Takeda Pharmaceutical … [Read more...] about Takeda Offers $2.2B to Settle Actos Claims
More than $2M Actos Bladder Cancer Case Award
Actos Bladder Cancer Case. A jury in a Pennsylvania state court awarded more than $2 million to a woman who claimed Takeda Pharmaceuticals’ diabetes medication Actos (pioglitazone) caused her bladder cancer. The plaintiff’s case alleged that Takeda officials failed to adequately warn Frances Wisniewski’s doctor about the … [Read more...] about More than $2M Actos Bladder Cancer Case Award
Blue Cross Sues Takeda
Bladder cancer risks associated with the Type 2 diabetes. Blue Cross and Blue Shield of Massachusetts filed subrogation actions last week in the Louisiana multidistrict litigation (MDL) over the bladder cancer risks associated with the Type 2 diabetes drug Actos. Blue Cross seeks to recover the cost of medical bills for hundreds of … [Read more...] about Blue Cross Sues Takeda
Sanctions Against Attorneys for Misconduct in Actos Trial
Misconduct In Actos Trial. A Las Vegas district judge is considering whether to impose sanctions against lawyers for misconduct during a trial over the diabetes drug Actos, manufactured by Takeda Pharmaceuticals. Last week, Judge Kerry Earley heard arguments that Takeda’s defense team violated court orders and treated the judge … [Read more...] about Sanctions Against Attorneys for Misconduct in Actos Trial
First Trial over Actos Bladder Cancer Lawsuits
Actos Bladder Cancer Lawsuits First Trial. The first Actos bladder cancer bellwether trial is taking place this Monday in the U.S. District Court for the Western District of Louisiana. Plaintiffs’ Terence and Susan Allen will be the first of 2,700 cases going to trial in the federal litigation. Their lawsuit alleges that … [Read more...] about First Trial over Actos Bladder Cancer Lawsuits
First Bellwether Trial Begins
Thousands Of Patients Developed Bladder Cancer The first Actos bellwether trial is moving forward and jury selection has taken place. Thousands of patients in the ongoing Actos litigation allege that they developed bladder cancer as a result of taking Actos (pioglitazone). Specifically, the couple who brought the case in the first … [Read more...] about First Bellwether Trial Begins
Takeda Hid Actos Cancer Risks
3,000 Lawsuits Faced By Actos In what is the first of more than 3,000 lawsuits against the diabetes medication Actos to reach trial, attorneys for the plaintiff revealed to jurors that Takeda Pharmaceutical Co., maker of the diabetes drug, had concealed that there were cancer risks associated with it. As early as 2004, Takeda’s … [Read more...] about Takeda Hid Actos Cancer Risks
Impact of Known Bladder Cancer Risk Linked to Actos
Bladder Cancer Risk Linked to Actos. Executives at Takeda Pharmaceuticals secretly surveyed doctors about a decade ago to determine if they would prescribe a drug that was linked to cancer, the most troubling side effect of its top-selling drug, Actos. According to a Bloomberg report, the company asked a dozen doctors back in 2003 … [Read more...] about Impact of Known Bladder Cancer Risk Linked to Actos
Man Diagnosed with Bladder Cancer after Taking Actos
Actos-Related Bladder Cancer. A Pennsylvania man has become the latest to claim that taking the type 2 diabetes drug Actos has resulted in him being stricken with bladder cancer. A lawsuit has been filed on his behalf in U.S. District Court for the Western District of Louisiana. The claim will be consolidated with other similar … [Read more...] about Man Diagnosed with Bladder Cancer after Taking Actos
Lawsuit Alleging Actos Caused the Cancer
Harmful Effects of Actos Drug. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a North Carolina man. The suit was filed on September 17th in the U.S. District Court for the Western District of … [Read more...] about Lawsuit Alleging Actos Caused the Cancer
NY Man Alleges that Actos Caused Bladder Cancer
Diabetes Medication Actos Caused Bladder Cancer. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a man who developed bladder cancer after taking Actos. The lawsuit alleges that Actos caused the cancer and claims that the … [Read more...] about NY Man Alleges that Actos Caused Bladder Cancer
Most Type 2 Diabetics Should Avoid Taking Actos
Type 2 Diabetics Should Avoid Taking Actos. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, is informing the public about a new report that recommends against using the Type 2 diabetes medication Actos unless all other options fail. According to Consumer … [Read more...] about Most Type 2 Diabetics Should Avoid Taking Actos
Defective Drug Lawyers File Lawsuit on Actos
Defective Drug Lawyers File Lawsuit On Behalf Of Patient Who Took Actos. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a Kentucky woman naming Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda … [Read more...] about Defective Drug Lawyers File Lawsuit on Actos
PW Files Another Actos Bladder Cancer Lawsuit
Actos Bladder Cancer Lawsuit. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli … [Read more...] about PW Files Another Actos Bladder Cancer Lawsuit
Study Ties Actos to Higher Bladder Cancer Risk
Actos Bladder Cancer Risk. A new study published in the Canadian Medical Association Journal has found that diabetics who use Actos (pioglitazone) face a higher risk of developing bladder cancer. The publication of the study comes just a little over a years since the ‘Actos’ label was updated to warn that patients who take … [Read more...] about Study Ties Actos to Higher Bladder Cancer Risk
Diabetic Macular Edema a Possible Avandia
The Possible Diabetic Macular Edema Risk Of Taking Actos, Avandia. A new study is raising more concerns about the possible side effects of thiazolidinediones, a group of drugs that includes Actos and Avandia. The study, published in the Archives of Internal Medicine, found that type 2 diabetes who took either Actos or … [Read more...] about Diabetic Macular Edema a Possible Avandia
Actos Increases Bladder Cancer Risks
Actos Increases Bladder Cancer Risks. More bad news today for patients taking Actos (pioglitazone), as another study has found a link between the type 2 diabetes drug and bladder cancer. The research, published in the British Medical Journal, found that patients taking Actos are more than 80 percent more likely to develop bladder … [Read more...] about Actos Increases Bladder Cancer Risks
Actos Bladder Cancer Warning
Actos Bladder Cancer Warning. Doctors and patients in Canada have been warned that taking Actos for more than a year may increase the risk of developing bladder cancer. In an alert issued last month, Health Canada said that Takeda Pharmaceuticals, the maker of Actos, had agreed to update the drug's Canadian label to warn of … [Read more...] about Actos Bladder Cancer Warning
PW Managing Partner Appointed to Actos Lawsuit Committee
Actos Bladder Cancer Lawsuit Committee. Jerrold Parker, Managing Partner with Parker Waichman LLP, has been appointed to the Plaintiffs' Steering Committee in the growing Actos bladder cancer lawsuit multidistrict litigation, Re: Actos Products Liability Litigation, 11-2299, U.S. District Court, Western District of Louisiana … [Read more...] about PW Managing Partner Appointed to Actos Lawsuit Committee
Kentucky Man’s Death Blamed on Actos
Bladder Cancer Blamed to Diabetes Drug Actos. The death of a Kentucky man due to bladder cancer is being blamed on the type 2 diabetes drug Actos in a federal lawsuit recently filed on behalf of his estate. The Plaintiff-Decedent is being represented by the national law firm of Parker Waichman LLP and the lawsuit has … [Read more...] about Kentucky Man’s Death Blamed on Actos
Actos Bladder Cancer Plaintiffs Ask for MDL
Actos Bladder Cancer Plaintiffs Seeks Pending Claims. Consolidated Plaintiffs in an Actos bladder cancer lawsuit are seeking to have all future and pending claims consolidated in a multidistrict litigation and transferred to U.S. District Court for the Southern District of Illinois. In a motion filed with the U.S. … [Read more...] about Actos Bladder Cancer Plaintiffs Ask for MDL
Actos Lawsuit Tidal Wave Expected
Actos Lawsuit Tidal Wave Expected. Plaintiffs' lawyers across the country are poised to file hundreds of Actos bladder cancer lawsuits, according to a report from the Associated Press. Over the past year, evidence linking Actos to bladder cancer has grown, and this summer, regulators in both Europe and the U.S. mandated stronger … [Read more...] about Actos Lawsuit Tidal Wave Expected
Actos Bladder Cancer Lawsuit Expected
Actos Bladder Cancer Lawsuit. Actos maker Takeda Pharmaceuticals can expect to be named in hundreds of bladder cancer lawsuits. Several plaintiffs lawyers recently told the Associated Press that their firms are preparing to file more than a hundred cases each, and they continue hear from more alleged Actos bladder cancer victims … [Read more...] about Actos Bladder Cancer Lawsuit Expected
Actos Recall Ordered in France
Actos Recall Due To Risk Of Bladder Cancer. Actos will be officially withdrawn from the market in France, one month after officials suspended its sales there because of a study that found people taking Actos faced a greater risk of developing bladder cancer. Two studies have recently pointed to an association between Actos and … [Read more...] about Actos Recall Ordered in France
Actos Study Sees Higher Diabetic Macular Edema Risk
Blinding Eye Disorder Called Macular Edema Side Effecf in Avandia, Actos. People taking the diabetes medications Actos or Avandia have yet another side effect to worry about - a potentially blinding eye disorder called diabetic macular edema. Diabetics are already vulnerable for this disease, which causes damage to retinal … [Read more...] about Actos Study Sees Higher Diabetic Macular Edema Risk
Long-Term Actos Use May Increase Bladder Cancer Risk
Actos Bladder Cancer Risk Taking the diabetes drug Actos (pioglitazone) for more than a year could put users at risk for bladder cancer, according to a new Drug Safety Communication issued by the U.S. Food & Drug Administration (FDA). The FDA is advising doctors not to prescribe Actos to people with active bladder … [Read more...] about Long-Term Actos Use May Increase Bladder Cancer Risk
Consolidation Ordered for Actos Lawsuits
Actos Bladder Cancer Lawsuits. According to a release from the Judicial Panel on Multidistrict Litigation (JPML) announcing the formation of MDL for all federal lawsuits involving Actos’ link to bladder cancer, an initial 11 cases plus at least 100 more have now been consolidated before Judge Rebecca F. Doherty in the U.S. … [Read more...] about Consolidation Ordered for Actos Lawsuits
